Marchex (MCHX) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
24 Dec, 2025Executive summary
Achieved foundational progress in 2024, including completion of the One Stack cloud-based architecture and foundational infrastructure initiatives to unify data assets and optimize scalability.
Focused on building a $100 million-plus revenue business, with 2025 positioned for acceleration and growth.
Expanded product offerings with new AI-powered solutions for lead identification and value assessment, targeting automotive, home services, and medical sectors, and introduced a unified user interface.
Strengthened go-to-market strategy, customer relationships, and sales force expansion, targeting large enterprises and new verticals.
Announced partnership with Microsoft to join the Cloud AI Partner Program, with Azure Marketplace launch expected in Q2 2025.
Financial highlights
Q4 2024 revenue was $11.9 million, down from $12.4 million in Q4 2023; full-year 2024 revenue was $48.1 million, down from $49.9 million in 2023.
Adjusted EBITDA loss of $386,000 in Q4 2024, compared to a positive $112,000 in Q4 2023; full-year 2024 Adjusted EBITDA was $(230,000), or $5,000 excluding $235,000 in reorganization costs.
GAAP net loss of $1.9 million ($0.04 per diluted share) in Q4 2024, versus $1.1 million loss ($0.02 per share) in Q4 2023; full-year net loss was $4.9 million ($0.11 per share) vs. $9.9 million ($0.23 per share) in 2023.
Ended Q4 2024 with $12.8 million in cash, down from $14.6 million at year-end 2023.
Cost of revenue for 2024 was $17.2 million, down from $20.6 million in 2023.
Outlook and guidance
Q1 2025 revenue and adjusted EBITDA expected to be in line with Q4 2024, factoring in higher operating and seasonal expenses.
Fiscal 2025 revenue anticipated to grow year-over-year, with sequential acceleration as new products and partnerships launch.
Gross margins for 2025 expected to improve over 2024, with positive adjusted EBITDA projected for the full year.
Management plans to reinvest potential gains from improved adjusted EBITDA into growth initiatives.
Latest events from Marchex
- AI-driven product launches and the Archenia deal set the stage for accelerated growth in 2026.MCHX
Q4 202525 Mar 2026 - Net loss narrowed and adjusted EBITDA improved as revenue is set to grow in Q3.MCHX
Q2 20242 Feb 2026 - Q3 2024 delivered $12.6M revenue, narrowed losses, and set the stage for AI-driven growth in 2025.MCHX
Q3 202417 Jan 2026 - Annual meeting to elect directors, ratify auditor, and highlight governance and compensation practices.MCHX
Proxy Filing1 Dec 2025 - Director elections, auditor ratification, and performance-based compensation highlight strong governance.MCHX
Proxy Filing1 Dec 2025 - Annual proxy details director elections, voting proposals, and governance disclosures.MCHX
Proxy Filing1 Dec 2025 - Q1 2025 revenue $11.4M, net loss $2.0M, gross margin 63%, targeting $50M+ run rate.MCHX
Q1 202525 Nov 2025 - Q2 2025 saw revenue dip 3% but net income and operational efficiency improved.MCHX
Q2 202523 Nov 2025 - Q3 revenue fell, but profitability improved and Archenia acquisition aims for accelerated AI growth.MCHX
Q3 202517 Nov 2025